{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:22:24Z","timestamp":1787764944592,"version":"build-2784847793"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Androgenetic alopecia (AGA) is defined as progressive, patterned hair loss that occurs as a result of androgen-mediated conversion of terminal hairs to vellus hairs. By the age of 60 years, 45% of men and 35% of women develop AGA. The Hamilton\u2013Norwood scale is used to assess the extent and severity of AGA and classify the stages of male pattern hair loss in men, whereas the Ludwig scale is preferred for women. Currently, U.S. Food and Drug Administration-approved treatments for AGA include oral finasteride and topical minoxidil. Due to the limited number of effective therapies for AGA, platelet-rich plasma (PRP) has become an effective alternative treatment. A number of studies on PRP have shown promising results, leading to increased hair density and thickness with minimal or no side effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>We aim to study the safety, efficacy, and side effects of PRP therapy in patients of AGA and to study demographic data in the form of age, sex, age of onset of hair loss, and grade of AGA in patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Fifty patients, 38 males and 12 females, with AGA were enrolled in the study. PRP was prepared using a double-spin method. Upon activation, PRP was injected in the involved areas of scalp once every 2 weeks for 6 months. Follow-up photos were taken every 3 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>At 6 months, majority of the patients (45%) were unsatisfied and showed no change in hair growth after PRP therapy and few patients were lost in follow-up. Adverse effects were minimal and no long-term serious adverse effects were noted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>We conclude from the results in our study that PRP therapy is not significantly effective in treatment of AGA. There is a need to develop standard protocols with regard to total length of PRP therapy and spacing between the two sessions of PRP for AGA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijt.ijt_31_21","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T07:00:09Z","timestamp":1701673209000},"page":"98-104","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Platelet-Rich Plasma in Androgenetic Alopecia: Is It Really Worth the Hype?"],"prefix":"10.4103","volume":"15","author":[{"given":"Pooja","family":"Agarwal","sequence":"first","affiliation":[{"name":"Department of Dermatology, SCL Hospital, N.H.L. Medical College, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna M.","family":"Gajjar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, SCL Hospital, N.H.L. Medical College, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Jagati","sequence":"additional","affiliation":[{"name":"Department of Dermatology, SCL Hospital, N.H.L. Medical College, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal V.","family":"Chaudhari","sequence":"additional","affiliation":[{"name":"Department of Dermatology, SCL Hospital, N.H.L. Medical College, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santoshdev P.","family":"Rathod","sequence":"additional","affiliation":[{"name":"Department of Dermatology, SCL Hospital, N.H.L. Medical College, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"R1-20240903","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2010.10011.x","article-title":"S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents","volume":"164","author":"Blume-Peytavi","year":"2011","journal-title":"Br J Dermatol"},{"key":"R2-20240903","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1055\/s-0028-1102905","article-title":"Understanding and management of female pattern alopecia","volume":"24","author":"Leavitt","year":"2008","journal-title":"Facial Plast Surg"},{"key":"R3-20240903","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1185\/030079905X61820","article-title":"The psychosocial impact of hair loss among men:A multinational European study","volume":"21","author":"Alfonso","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"R4-20240903","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0190-9622(93)70223-G","article-title":"Psychological effects of androgenetic alopecia on women:Comparisons with balding men and with female control subjects","volume":"29","author":"Cash","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"R5-20240903","first-page":"457","article-title":"A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women","volume":"17","author":"Lee","year":"2018","journal-title":"Journal of drugs in dermatology"},{"key":"R6-20240903","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2217\/rme.13.59","article-title":"Platelet-rich plasma:Underlying biology and clinical correlates","volume":"8","author":"Andia","year":"2013","journal-title":"Regen Med"},{"key":"R7-20240903","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/01.PRS.0000138251.07040.51","article-title":"Platelet quantification and growth factor analysis from platelet-rich plasma:Implications for wound healing","volume":"114","author":"Eppley","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"R8-20240903","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1054\/jcms.2002.0285","article-title":"Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count","volume":"30","author":"Weibrich","year":"2002","journal-title":"J Craniomaxillofac Surg"},{"key":"R9-20240903","doi-asserted-by":"crossref","first-page":"532519","DOI":"10.1155\/2012\/532519","article-title":"Platelet-rich plasma peptides:Key for regeneration","volume":"2012","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2012","journal-title":"Int J Pept"},{"key":"R10-20240903","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/1523-1747.ep12616668","article-title":"Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin","volume":"99","author":"Tavakkol","year":"1992","journal-title":"J Invest Dermatol"},{"key":"R11-20240903","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/0378-6323.125467","article-title":"Platelet-rich plasma in dermatology:Boon or a bane?","volume":"80","author":"Arshdeep Kumaran","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R12-20240903","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/01.prs.0000239560.29172.33","article-title":"The role of platelet plasma growth factors in male pattern baldness surgery","volume":"118","author":"Uebel","year":"2006","journal-title":"Plast Reconstr Surg"},{"key":"R13-20240903","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1365-2133.2010.09640.x","article-title":"Prevalence of androgenetic alopecia in China:A community-based study in six cities","volume":"162","author":"Wang","year":"2010","journal-title":"Br J Dermatol"},{"key":"R14-20240903","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/0974-7753.58556","article-title":"Male androgenetic alopecia:Population-based study in 1,005 subjects","volume":"1","author":"Krupa Shankar","year":"2009","journal-title":"Int J Trichology"},{"key":"R15-20240903","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2133.2001.04289.x","article-title":"The prevalence and types of androgenetic alopecia in Korean men and women","volume":"145","author":"Paik","year":"2001","journal-title":"Br J Dermatol"},{"key":"R16-20240903","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2133.2005.06442.x","article-title":"A study of patterns of androgenetic alopecia in men:An Indian perspective","volume":"152","author":"Grover","year":"2005","journal-title":"Br J Dermatol"},{"key":"R17-20240903","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1468-3083.2006.01920.x","article-title":"Male pattern androgenetic alopecia in an Indian context:A perspective study","volume":"21","author":"Sehgal","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 6","key":"R18-20240903","first-page":"S1","article-title":"Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men","volume":"9","author":"Blumeyer","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"R19-20240903","first-page":"1","article-title":"Promising therapies for treating and\/or preventing androgenic alopecia","volume":"17","author":"McElwee","year":"2012","journal-title":"Skin Therapy Lett"},{"key":"R20-20240903","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/SAP.0b013e3181d59f60","article-title":"From surgery to pharmacology to gene therapy:The past, present, and future of hair restoration","volume":"65","author":"Jandali","year":"2010","journal-title":"Ann Plast Surg"},{"key":"R21-20240903","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/01.DSS.0000452629.76339.2b","article-title":"Platelet-rich plasma for androgenetic alopecia:A pilot study","volume":"40","author":"Schiavone","year":"2014","journal-title":"Dermatol Surg"},{"key":"R22-20240903","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/DSS.0000000000000665","article-title":"Randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia","volume":"42","author":"Alves","year":"2016","journal-title":"Dermatol Surg"},{"key":"R23-20240903","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/ijt.ijt_64_18","article-title":"A study to compare the efficacy of platelet-rich plasma and minoxidil therapy for the treatment of androgenetic alopecia","volume":"11","author":"Verma","year":"2019","journal-title":"Int J Trichology"},{"key":"R24-20240903","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/ijt.ijt_75_16","article-title":"A comparative study of microneedling with platelet-rich plasma plus topical minoxidil (5%) and topical minoxidil (5%) alone in androgenetic alopecia","volume":"9","author":"Shah","year":"2017","journal-title":"Int J Trichology"},{"key":"R25-20240903","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0974-2077.138352","article-title":"Platelet-rich plasma in androgenic alopecia:Myth or an effective tool","volume":"7","author":"Khatu","year":"2014","journal-title":"J Cutan Aesthet Surg"},{"key":"R26-20240903","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/DSS.0000000000001049","article-title":"The effect of plasma rich in growth factors on pattern hair loss:A pilot study","volume":"43","author":"Anitua","year":"2017","journal-title":"Dermatol Surg"},{"key":"R27-20240903","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/DSS.0000000000000883","article-title":"Double-blind, placebo-controlled pilot study on the use of platelet-rich plasma in women with female androgenetic alopecia","volume":"42","author":"Puig","year":"2016","journal-title":"Dermatol Surg"},{"key":"R28-20240903","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/14764172.2016.1225963","article-title":"Efficacy of platelet-rich plasma in the treatment of androgenetic (male-patterned) alopecia:A pilot randomized controlled trial","volume":"18","author":"Mapar","year":"2016","journal-title":"J Cosmet Laser Ther"}],"container-title":["International Journal of Trichology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijt.ijt_31_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:53:02Z","timestamp":1787763182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijt.ijt_31_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijt.ijt_31_21","relation":{},"ISSN":["0974-7753","0974-9241"],"issn-type":[{"value":"0974-7753","type":"print"},{"value":"0974-9241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"2021-03-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}